OakChart

Ardent Health Inc

ARDTHealthcare·Medical Care Facilities·USA·Mid·NYSE·Nov 13 • 7:15 AM ET

17.58-0.10 (-0.57%)
2026-11-13 13:18 CET
Market cap
$2.48B
Revenue, TTM
6,454.05 USD m
Net income, TTM
146.22 USD m
Free cash flow, TTM
282.30 USD m
EPS diluted, TTM
1.03
Price / earnings
17.07
Compare

Price

ARDT against its 20, 50 and 200-day averages
Terms2050200BeatMiss
Patternshover a marker to name it
RS 33Sales 1,641Price1,6311,6347.5010.0012.5015.0017.501.7M3.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ARDTclose 17.5820-day 13.9950-day 12.14200-day 10.3517.5852w high 18.5752w low 7.7152-week range, not 6 months

5.3% under the 52-week high of 18.57 on 9 Nov 2026. 52-week low 7.71 on 3 Jun 2026. Last 15 sessions, 60.8% high to low

Volume 0.02× normal · the line is the 50-bar volume average

Setup. RS line 33
CANSLIM 4 of 6 — fails: EPS Growth This Year: High (>25%); Institutional Ownership: Over 50%
VCP 5 of 6 — fails: RSI (14): Not Overbought (<60)
Minervini 4 of 4
Zanger 2 of 5 — fails: Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 5 of 5
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 1 of 4 — fails: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1)
Value 1 of 4 — fails: P/E: Under 15; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 2 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%
Small Cap 4 of 4
Accumulation 2 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%

Profile

ARDT
52-week range, 91% of the way up
7.7118.57

Ardent Health, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals through its subsidiaries. The company was founded in 1993 and is headquartered in Brentwood, TN.

IndexRUT
Employees25200
IPOJul 18, 2024
Beta0.42
ATR, 14d0.76
Rel volume0.02
Short float15.69%
Insider own84.41%
Inst own15.90%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$2.48B
Enterprise Value4.36B
Income146.22M
Sales6.45B
Book / share9.91
Cash / share5.44
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees25200
IPOJul 18, 2024

Ratios

Price / earnings17.07
Forward price / earnings13.96
Price / earnings / growth1.34
Price / sales0.38
Price / book1.77
Price / cash3.23
Price / free cash flow8.78
Value / cash profit8.67
Value / sales0.68
Quick Ratio2.03
Current Ratio2.13
Debt / equity1.62
Long-term debt / equity1.60
Options and shortYes / Yes

Earnings

Earnings / share1.03
Earnings next year1.26
Earnings next quarter0.36
Earnings this year10.95%
Earnings next year18.28%
Earnings growth, 5 years10.44%
Past earnings growth-10.04% -
Past sales growth7.23% 8.73%
Earnings vs last year-28.50%
Sales vs last year2.03%
Earnings vs last quarter289.05%
Sales vs last quarter3.05%
EarningsNov 04 AMC
Surprise33.62% 1.31%

Ownership

Insiders own84.41%
Insider trades0.02%
Institutions own15.90%
Institution trades0.92%
Return on assets2.78%
Return on equity11.10%
Return on capital4.03%
Gross Margin15.40%
Operating margin5.22%
Profit Margin2.27%
20-day average25.68%
50-day average44.80%
200-day average69.79%

Technical

Shares out140.93M
Shares floating21.97M
Short / float15.69%
Short ratio6.43
Short interest3.45M
52-week high18.57 -5.3%
52-week low7.71 +128.0%
Volatility6.57% 4.94%
Average range0.76
Strength index78.95
Market sensitivity0.42
Relative volume0.02
Avg Volume536.17K
Volume658

Performance

Perf Week1.62%
Perf Month44.10%
Perf Quarter61.43%
Perf Half Y74.06%
Perf YTD99.09%
Perf Year89.03%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recommendation1.82
Target Price16.95
Prev Close17.68
Price17.58
Change %-0.57%

Analyst ratings

latest 10 of 19
DateActionAnalystRating changeTargetImplied
Sep 23, 2026InitiatedBMO Capital MarketsMarket Perform$11-37.4%
Nov 17, 2025DowngradeKeyBanc Capital MarketsOverweight → Sector Weight
Nov 14, 2025DowngradeMorgan StanleyOverweight → Equal-Weight
Oct 14, 2025InitiatedGoldmanNeutral$19+8.1%
Sep 10, 2025InitiatedUBSBuy$17-3.3%
Jul 16, 2025DowngradeBofA SecuritiesNeutral → Underperform$14.60-17.0%
Dec 17, 2024ResumedJP MorganNeutral$20+13.8%
Nov 06, 2024DowngradeBofA SecuritiesBuy → Neutral$22 → $19+8.1%
Oct 11, 2024InitiatedKeyBanc Capital MarketsOverweight$24+36.5%
Aug 12, 2024InitiatedTruistBuy$21+19.5%

Peers

Mkt cap
TickerCompanyMkt cap
CYHCommunity Health Systems Inc311.67M
UHSUniversal Health Services Inc11.15B
THCTenet Healthcare Corp22.92B
HCAHCA Healthcare Inc105.07B
NUTXNutex Health Inc1.18B
SGRYSurgery Partners Inc3.42B
ACHCAcadia Healthcare Company Inc3.52B
AUNAAuna SA338.24M
EHCEncompass Health Corp13.82B
MDPediatrix Medical Group Inc2.45B

Insider trading

6 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Bonick MartinFormer Officer & DirectorAug 27 '26Proposed Sale11.0835,930398,031Aug 27 04:18 PM
Bonick MartinFormer Officer & DirectorAug 25 '26Proposed Sale11.1735,930401,355Aug 25 04:47 PM
Bonick MartinFormer Officer & DirectorAug 20 '26Proposed Sale10.5035,930377,364Aug 20 04:23 PM
Bonick MartinFormer Officer & DirectorAug 18 '26Proposed Sale10.9535,930393,482Aug 18 04:11 PM
DeMichiei RobertDirectorJun 05 '26Buy8.7311,26098,30035,564Jun 08 12:50 PM
LUMSDAINE ALFREDChief Financial OfficerJun 05 '26Buy8.8110,00088,100329,183Jun 08 12:50 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 33.08B
IWMiShares Russell 2000 Index FundAUM: 77.86B
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.45B
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
FYXFirst Trust Small Cap Core AlphaDEX FundAUM: 1.40B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.56B
IWNiShares Russell 2000 Value ETFAUM: 14.17B
EESWisdomTree U.S. SmallCap FundAUM: 690.24M
VXFVanguard Extended Market Index ETFAUM: 30.79B
SCHASchwab U.S. Small-Cap ETFAUM: 22.44B

News

latest 14 of 100

Quarterly earnings

2026Q3 EPS 0.310 beat 0.232, from -0.170 a year earlier. Sales 1,625 beat 1,604, from 1,577 a year earlier
EPS
0.8100-0.1702024Q4 EPS 0.810 against 0.47624Q42025Q1 EPS 0.290 against 0.20125Q12025Q2 EPS 0.520 against 0.22625Q22025Q3 EPS -0.170 against 0.41925Q32025Q4 EPS 0.320 against 0.31725Q42026Q1 EPS 0.280 against 0.19126Q12026Q2 EPS 0.120 against 0.18226Q22026Q3 EPS 0.310 against 0.23226Q3
Sales, USD millions
1,64502024Q4 sales 1,606 against 1,48424Q42025Q1 sales 1,497 against 1,49825Q12025Q2 sales 1,645 against 1,51025Q22025Q3 sales 1,577 against 1,54925Q32025Q4 sales 1,605 against 1,63125Q42026Q1 sales 1,602 against 1,57826Q12026Q2 sales 1,622 against 1,59026Q22026Q3 sales 1,625 against 1,60426Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-04 16:300.3100.2320.3111,6251,604EPS +33.6% · sales +1.3%vs 2025Q3, year-ago quarter · EPS -282.4% · sales +3.1%10 EPS · 12 salesOpen +12.78% vs SPY -0.17%. Close +22.40% vs SPY -4.41%
2026Q2ended 2026-06-302026-08-04 16:300.1200.1820.1181,6221,590EPS -34.0% · sales +2.0%vs 2025Q2, year-ago quarter · EPS -76.9% · sales -1.4%11 EPS · 10 salesOpen +7.07% vs SPY +0.59%. Close +3.81% vs SPY -0.20%
2026Q1ended 2026-03-312026-05-05 16:300.2800.1910.2811,6021,578EPS +46.8% · sales +1.5%vs 2025Q1, year-ago quarter · EPS -3.4% · sales +7.0%10Open -1.58% vs SPY +0.61%. Close -7.50% vs SPY +1.39%
2025Q4ended 2025-12-312026-03-04 16:300.3200.3170.3161,6051,631EPS +1.0% · sales -1.6%vs 2024Q4, year-ago quarter · EPS -60.5% · sales -0.1%11 EPS · 12 salesOpen -10.58% vs SPY -0.45%. Close -2.07% vs SPY -0.56%
2025Q3ended 2025-09-302025-11-12 16:30-0.1700.419-0.1661,5771,549EPS -140.6% · sales +1.8%vs 2024Q3, year-ago quarter · EPS -189.5% · sales +8.8%11Open -33.59% vs SPY -0.42%. Close -33.81% vs SPY -1.66%
2025Q2ended 2025-06-302025-08-05 16:300.5200.2260.5161,6451,510EPS +130.0% · sales +8.9%vs 2024Q2, year-ago quarter · EPS +52.9% · sales +11.9%8Open +10.70% vs SPY +0.17%. Close +6.10% vs SPY +0.77%
2025Q1ended 2025-03-312025-05-06 16:300.2900.2010.2941,4971,498EPS +44.3% · sales 0.0%vs 2024Q1, year-ago quarter · EPS +42.2% · sales +4.0%9Open +4.84% vs SPY +0.24%. Close +9.22% vs SPY +0.42%
2024Q4ended 2024-12-312025-02-26 16:300.8100.4760.8001,6061,484EPS +70.1% · sales +8.2%-8 EPS · 9 salesOpen +11.28% vs SPY +0.39%. Close +8.21% vs SPY -1.60%
2024Q3ended 2024-09-302024-11-06 16:300.1900.3090.1841,4501,452EPS -38.4% · sales -0.2%-9Open -3.69% vs SPY +0.35%. Close +7.81% vs SPY +0.77%
2024Q2ended 2024-06-302024-08-14 16:300.3400.3070.3001,4711,460EPS +10.9% · sales +0.7%-9 EPS · 8 salesOpen +8.06% vs SPY +1.06%. Close +6.06% vs SPY +1.71%
2024Q1ended 2024-03-312024-05-29 12:000.204-0.1891,439-EPS - · sales ----
2026Q4ended 2026-12-31--0.363--1,641EPS - · sales -vs 2025Q4, year-ago quarter · EPS - · sales -10-
2027Q1ended 2027-03-31--0.295--1,643EPS - · sales -vs 2026Q1, year-ago quarter · EPS - · sales -7 EPS · 6 sales-
2027Q2ended 2027-06-30--0.235--1,662EPS - · sales -vs 2026Q2, year-ago quarter · EPS - · sales -7 EPS · 6 sales-
2027Q3ended 2027-09-30--0.319--1,657EPS - · sales -vs 2026Q3, year-ago quarter · EPS - · sales -7 EPS · 6 sales-
2027Q4ended 2027-12-31--0.389--1,696EPS - · sales -vs 2026Q4, year-ago quarter · EPS - · sales -6 EPS · 5 sales-

Annual earnings

2025FY EPS 0.960 missed 1.048, from 1.580 a year earlier. Sales 6,324 missed 6,356, from 5,966 a year earlier
EPS
1.58002024FY EPS 1.580 against 1.21320242025FY EPS 0.960 against 1.0482025
Sales, USD millions
6,35602024FY sales 5,966 against 5,84320242025FY sales 6,324 against 6,3562025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2028FYestimate-1.293--6,95913.60
2027FYestimate-1.260--6,66013.96
2026FYestimate-1.065--6,48916.51
2025FY0.9601.0480.9606,3246,3569.20
2024FY1.5801.2131.4745,9665,84310.81

Quarterly results

2026Q3 revenue 1,625, from 1,577 a year earlier. Operating margin 5.9%, from 1.0% a year earlier
Revenue, USD millions
1,64502024Q4 revenue 1,60624Q42025Q1 revenue 1,49725Q12025Q2 revenue 1,64525Q22025Q3 revenue 1,57725Q32025Q4 revenue 1,60525Q42026Q1 revenue 1,60226Q12026Q2 revenue 1,62226Q22026Q3 revenue 1,62526Q3
Operating margin
9.802024Q4 operating margin 9.8%24Q42025Q1 operating margin 4.5%25Q12025Q2 operating margin 8.3%25Q22025Q3 operating margin 1.0%25Q32025Q4 operating margin 6.5%25Q42026Q1 operating margin 5.1%26Q12026Q2 operating margin 3.4%26Q22026Q3 operating margin 5.9%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 1.07 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-131.07+1.0%
2026Q4Eper share2026-11-130.36+0.9%
2026FYRper share2026-11-131.05-0.9%
2026Q4Rper share2026-11-130.35-2.5%
2026FYSUSD millions2026-11-136,489+0.1%
2026Q4SUSD millions2026-11-131,641+0.1%
2026Q3Eper share2026-10-290.23-1.4%
2026Q3SUSD millions2026-10-231,6040.0%
2026Q3Rper share2026-10-200.230.0%
2026Q2Eper share2026-07-210.18-1.2%
2026Q2Rper share2026-07-210.16-8.7%
2026Q2SUSD millions2026-07-211,590-0.1%
2026Q1Eper share2026-04-060.19+3.5%
2026Q1Rper share2026-04-060.18+5.2%
2026Q1SUSD millions2026-04-061,578+0.2%
2025Q4SUSD millions2026-02-271,631+0.0%
2025FYEper share2026-02-041.120.0%
2025Q4Eper share2026-02-040.320.0%
2025FYRper share2026-02-040.960.0%
2025Q4Rper share2026-02-040.310.0%
2025FYSUSD millions2026-01-286,3560.0%
2025Q3SUSD millions2025-11-071,549+0.0%
2025Q3Eper share2025-10-270.420.0%
2025Q3Rper share2025-10-270.400.0%
2025Q2Eper share2025-08-010.23-25.2%
2025Q2Rper share2025-08-010.22-30.9%
2025Q2SUSD millions2025-08-011,510+0.0%
2025Q1SUSD millions2025-04-101,498+0.0%
2025Q1Eper share2025-04-090.20-0.4%
2025Q1Rper share2025-04-090.20-0.9%
2024Q4Eper share2025-02-120.470.0%
2024Q4Rper share2025-02-120.430.0%
2024Q4SUSD millions2025-02-121,4840.0%
2024Q3SUSD millions2024-11-011,452+0.0%
2024Q3Eper share2024-10-300.310.0%
2024Q3Rper share2024-10-290.270.0%
2024Q2Eper share2024-08-120.32-0.2%
2024Q2Rper share2024-08-090.28-
2024Q2SUSD millions2024-08-091,462-

Estimate history

Annual
Metric20152016201720212022202320242025TTMMRQ
EPS per share---1.0771.3190.3761.4740.961.0297-
Sales USD millions2,0292,1053,0024,8705,1305,4095,9666,3246,454-
Shares million shares253255386143143143143143-141
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share0.1840.80.2940.516-0.1660.3160.2810.1180.314
Sales USD millions1,4501,6061,4971,6451,5771,6051,6021,6221,625
Shares million shares143143143143143143143142141

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212017FY12/31/20172016FY12/31/2016
Total Revenue6,454.056,324.34+6.0%5,966.07+10.3%5,409.48+5.5%5,129.69+5.3%4,870.40-3,002.08+42.6%2,105.22
Cost of Goods Sold Incl. D&A5,460.345,351.45+5.7%5,064.09+6.8%4,741.90+6.2%4,465.02+6.4%4,196.86-2,663.14+42.3%1,871.20
Gross Profit993.71972.89+7.9%901.98+35.1%667.58+0.4%664.67-1.3%673.54-338.94+44.8%234.01
Other Operating Expense656.93647.31+30.4%496.22+9.8%451.80-2.7%464.46+25.1%371.16-218.72+46.5%149.26
Operating Income336.78325.58-19.8%405.76+88.0%215.78+7.8%200.20-33.8%302.38-120.22+41.9%84.75
Interest Expense47.8144.44-4.6%46.57-19.8%58.10-32.2%85.64-18.1%104.56-70.74+162.5%26.95
Unusual Expense0.00-15.31-1.52-8.46-35.47-86.55--1.55-107.6%20.49
Net Income Before Taxes291.19286.36-21.1%363.06+139.5%151.61-51.3%311.48+5.3%295.89-50.64+14.1%44.37
Income Taxes60.3656.22-11.3%63.35+179.8%22.64-50.9%46.11-10.1%51.31-49.87+521.8%8.02
Consolidated Net Income230.83230.13-23.2%299.71+132.4%128.98-51.4%265.37+8.5%244.58-0.77-97.9%36.35
Net Income From Continuing Operations146.22135.81-35.4%210.34+290.2%53.90-71.5%188.91+22.5%154.26--35.65-344.2%14.60
Net Income146.22135.81-35.4%210.34+290.2%53.90-71.5%188.91+22.5%154.26--35.65-344.2%14.60
EPS (Recurring) per share1.030.88-40.1%1.47+345.5%0.33-71.3%1.15+76.9%0.65---
EPS (Basic, Before Extraordinaries) per share1.040.96-34.7%1.47+286.8%0.38-71.2%1.32+22.2%1.08---
EPS (Diluted) per share1.030.96-34.7%1.47+286.8%0.38-71.2%1.32+22.2%1.08---
EBITDA503.20481.29-12.8%552.05+54.8%356.62+5.4%338.38-23.0%439.58-229.75+47.0%156.27
Non-Operating Income (Expense)2.22-10.10-531.6%2.34-14.53-109.0%161.45+1301.5%11.52--0.40-105.7%7.05
Other After Tax Adjustments0.000.000.000.000.000.00-0.000.00
Stock Option Compensation Expense27.8531.04+127.9%13.62+1818.3%0.71+47.9%0.48+20.0%0.40---
Price To Earnings Ratio ratio statement ratio, not the snapshot17.1717.1726.5325.83-----
Price To Sales Ratio ratio0.230.200.41------
Gross Margin %15.4015.3815.1212.3412.9613.83-11.2911.12
Operating Margin %5.225.156.803.993.906.21-4.004.03
Net Margin %2.272.153.531.003.683.17--1.190.69
Shares Outstanding million shares140.93142.86+0.1%142.75-0.4%143.260.0%143.260.0%143.26-385.54+51.1%255.23
Market Capitalization2,491.752,491.75+2.2%2,437.88+2.7%2,373.65-----

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue1,624.86+3.1%1,622.24-1.4%1,601.87+7.0%1,605.08-0.1%1,576.75+8.8%1,645.28+11.9%1,497.23+4.0%1,606.29+19.3%
Cost of Goods Sold Incl. D&A1,366.70+0.4%1,391.63+3.5%1,355.81+4.3%1,346.20+3.0%1,361.57+7.9%1,344.30+7.2%1,299.38+4.7%1,307.35+8.0%
Gross Profit258.16+20.0%230.61-23.4%246.06+24.4%258.88-13.4%215.17+14.4%300.98+38.5%197.86+0.1%298.94+120.0%
Other Operating Expense162.81-18.1%174.84+6.8%165.15+26.3%154.13+9.0%198.71+68.8%163.70+44.4%130.77+7.3%141.37+28.9%
Operating Income95.34+479.2%55.77-59.4%80.91+20.6%104.75-33.5%16.46-76.6%137.28+32.0%67.09-11.5%157.57+501.6%
Interest Expense15.61+42.0%11.15-5.8%10.74-5.0%10.30+4.3%10.99+15.6%11.84-34.8%11.30-41.3%9.88-25.4%
Unusual Expense0.00-100.0%0.00-100.0%0.00-100.0%0.007.700.56-65.9%0.22-4.70
Net Income Before Taxes81.0343.20-64.6%74.59+0.5%92.37-44.8%-2.20-103.9%121.99+48.4%74.20+31.2%167.25+1794.1%
Income Taxes17.648.51-67.6%16.10+5.7%18.11-31.3%-3.41-130.8%26.29+72.7%15.23+42.2%26.36
Consolidated Net Income63.39+5138.8%34.69-63.8%58.49-0.8%74.26-47.3%1.21-97.4%95.70+42.9%58.97+28.6%140.89+1207.0%
Net Income From Continuing Operations44.5216.90-76.8%39.85-3.7%44.96-60.6%-23.48-189.2%72.95+70.6%41.38+53.0%114.20
Net Income44.5216.90-76.8%39.85-3.7%44.96-60.6%-23.48-189.2%72.95+70.6%41.38+53.0%114.20
EPS (Recurring) per share0.310.12-76.9%0.28-6.7%0.32-59.0%-0.13-172.2%0.52+67.7%0.30+57.9%0.78
EPS (Basic, Before Extraordinaries) per share0.320.12-76.9%0.28-6.7%0.32-60.0%-0.17-194.4%0.52+73.3%0.30+57.9%0.80
EPS (Diluted) per share0.310.12-76.9%0.28-3.4%0.32-60.0%-0.17-194.4%0.52+73.3%0.29+52.6%0.80
EBITDA136.40+145.3%97.11-45.0%123.90+20.0%145.79-25.4%55.61-48.1%176.59+25.9%103.29-7.1%195.43+214.3%
Non-Operating Income (Expense)1.29+4200.0%-1.424.42-76.3%-2.08-114.0%0.03-2.8918.6214.85
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.31-4.3%6.28-29.3%7.05-3.7%7.20+0.1%7.64+18.8%8.88+4833.3%7.32+1730.0%7.19+5035.7%
Price To Earnings Ratio ratio statement ratio, not the snapshot17.1710.398.926.127.398.669.3426.53
Price To Sales Ratio ratio0.230.220.190.200.300.310.320.41
Gross Margin %15.8914.2215.3616.1313.6518.2913.2118.61
Operating Margin %5.873.445.056.531.048.344.489.81
Net Margin %2.741.042.492.80-1.494.432.767.11
Shares Outstanding million shares140.93-1.6%141.91-0.8%143.13+0.1%142.86+0.1%143.17+0.3%143.10+0.2%143.04-0.2%142.75-0.4%
Market Capitalization2,491.75+31.4%1,410.56-27.8%1,223.24-37.7%1,264.35-48.1%1,896.15-27.7%1,953.98-25.2%1,962.812,437.88

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY2017FY12/31/20172016FY12/31/20162015FY
Cash & Short Term Investments709.60+27.4%556.78+27.2%437.58-4.1%456.12--71.96-22.3%92.61-
Short Term Receivables761.70+1.7%749.03-4.7%785.76+28.4%611.96--453.85+73.9%261.04-
Inventories118.59+3.0%115.09+9.1%105.48-1.6%107.15--84.16+78.7%47.09-
Other Current Assets468.93+13.9%411.84+42.4%289.27+23.6%234.01--126.44+79.6%70.41-
Total Current Assets2,058.82+12.3%1,832.75+13.3%1,618.09+14.8%1,409.25--736.42+56.3%471.15-
Net Property, Plant & Equipment2,144.02+5.1%2,039.05+1.3%2,012.24+1.1%1,990.15--591.57+130.6%256.53-
Total Investments and Advances0.00-100.0%3.26-64.2%9.10-57.5%21.40--0.000.00-
Long-Term Note Receivable61.90+654.9%8.20-5.7%8.70+8.7%8.00-----
Intangible Assets968.79+4.3%929.01+0.8%921.630.0%921.63--896.44+183.4%316.27-
Deferred Tax Assets6.89-98.2%383.85-4.9%403.70-2.8%415.46--87.26+2290.7%3.65-
Other Assets49.79-62.1%131.50+1.7%129.31+37.6%93.98--62.83+66.4%37.76-
Total Assets5,290.21-0.7%5,327.63+4.4%5,102.77+5.0%4,859.88--2,374.52+118.8%1,085.36-
Short Term Debt Incl. Current Port. of LT Debt76.94+38.3%55.62-8.9%61.03+4.5%58.42--16.88+120.1%7.67-
Accounts Payable457.94+14.1%401.25-15.4%474.54+47.9%320.80--226.48+71.7%131.94-
Income Tax Payable15.01-1.2%15.20-15.6%18.02+3.9%17.35-----
Other Current Liabilities496.66+4.9%473.36+7.5%440.51+6.9%412.03--263.98+40.0%188.53-
Total Current Liabilities1,046.54+10.7%945.42-4.9%994.10+22.9%808.60--507.35+54.6%328.14-
Long Term Debt2,241.01+0.6%2,226.57-4.7%2,335.58+0.2%2,329.93--935.81+302.2%232.70-
Provision for Risks Charges0.000.000.000.00--0.000.00-
Deferred Tax Liabilities-371.53+0.1%371.21-2.6%381.03-----
Other Liabilities317.69+21.4%261.75-18.1%319.55+10.2%290.01--171.09+33.1%128.51-
Total Liabilities3,605.24-5.3%3,805.27-5.4%4,020.45+5.5%3,809.57--1,614.24+134.2%689.36-
Non-Equity Reserves0.000.000.000.00--0.000.00-
Preferred Stock - Carrying Value0.000.000.000.00--0.000.00-
Common Equity1,287.90+13.8%1,131.38+68.6%670.90+5.0%639.05--377.72+41.7%266.54-
Total Shareholders Equity1,287.90+13.8%1,131.38+68.6%670.90+5.0%639.05--377.72+41.7%266.54-
Accumulated Minority Interest397.07+1.6%390.98-5.0%411.42+0.0%411.26--382.55+195.5%129.47-
Total Equity1,684.96+10.7%1,522.36+40.7%1,082.32+3.0%1,050.31--760.28+92.0%396.01-
Total Liabilities & Stockholders Equity5,290.21-0.7%5,327.63+4.4%5,102.77+5.0%4,859.88--2,374.52+118.8%1,085.36-
Book Value Per Share per share9.01+13.6%7.93+69.4%4.68+4.9%4.46--0.98-5.8%1.04-
Tangible Book Value Per Share per share2.23+57.0%1.42-1.75-1.97---1.35-0.19-
Full-Time Employees people25,200+1.2%24,900-------
Price to Book Ratio ratio1.782.422.36------
Return on Assets %2.564.031.08----2.06--
Return on Equity %11.2323.348.23----11.07--
Return on Invested Capital %3.856.261.796.36---2.712.92-
Quick Ratio ratio1.851.821.521.61--1.291.29-
Current Ratio ratio1.971.941.631.74--1.451.44-

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212017FY12/31/20172016FY12/31/2016
Net Income230.83230.13-23.2%299.71+132.4%128.98-51.4%265.37+8.5%244.58-0.77-97.9%36.35
Depreciation166.42155.70+6.4%146.29+3.9%140.84+1.9%138.17+0.7%137.20-109.53+53.2%71.51
Other Funds (Non Cash)22.7841.85+56.5%26.74+538.2%4.19-162.36-385.3%56.90-9.41-52.2%19.68
Funds from Operations458.94471.28-5.1%496.78+78.7%278.01-3.2%287.30-29.6%408.03-169.41+47.5%114.83
Extraordinary Item0.000.000.000.000.000.00-0.000.00
Changes in Working Capital22.94-3.34-181.75-56.31-325.65-261.12--49.94-30.71
Cash from Operating Activities481.88467.94+48.5%315.03+42.1%221.70-38.36-126.1%146.91-119.47+42.0%84.12
Capital Expenditures-199.57-211.90-187.51-137.41-151.11-139.00--121.53-80.50
Net Assets From Acquisitions-2.50-2.50-35.540.000.00-2.93--899.30-22.85
Sale of Fixed Assets and Businesses0.000.00-100.0%4.300.00-100.0%206.37+4813.6%4.20-41.75+115.7%19.36
Purchase or Sale of Investments0.000.000.000.000.000.00-0.000.00
Purchase of Investments0.000.000.000.000.000.00-0.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00-0.000.00
Other Uses0.090.00-1.71-0.57-8.690.00--4.19-1.19
Other Sources8.540.180.000.000.00-100.0%1.47-0.000.00
Cash from Investing Activities-193.45-214.23-220.46-137.98-396.2%46.58-136.26--983.27-85.19
Cash Dividends Paid0.000.000.000.00-174.81-62.13-0.000.00
Change in Capital Stock-24.010.00-100.0%199.120.000.000.00-143.940.00
Repurchase of Common Pref Stock-24.010.000.000.000.000.00-0.000.00
Sale of Common Pref Stock0.000.00-100.0%199.120.000.000.00-143.940.00
Proceedsfrom Stock Options0.000.00-100.0%199.120.000.000.00-143.940.00
Issuance or Reduction of Debt, Net-14.26-7.99-107.22-7.03-16.41-138.28-699.99-5.67
Change in Long Term Debt-14.26-7.99-107.22-7.03-16.41-138.28-671.99-5.67
Issuance of Long Term Debt0.000.00-100.0%1.15-99.1%131.62-35.1%202.93-82.2%1,141.75-681.470.00
Reduction of Long Term Debt-14.26-7.99-108.37-138.65-219.34-1,280.02--9.49-5.67
Net Financing Active Other Cash Flow-93.36-92.90-67.26-95.24-79.11-83.50--0.77-143.0%1.79
Other Financing Activities Uses-116.85-108.51-83.30-119.98-83.45-86.86--9.44-7.76
Cash from Financing Activities-131.63-100.89-509.5%24.64-102.26-270.33-283.91-843.15-3.88
Net Change in Cash156.80152.82+28.2%119.21-18.55-262.11-273.26--20.65-4.95
Free Cash Flow282.30256.03+100.8%127.52+51.3%84.29-189.47-2495.3%7.91--2.06-156.9%3.62
Preferred Dividends (Cash Flow)-0.000.000.000.000.00-0.000.00
Price to Free Cash Flow ratio5.194.8819.12------
Deferred Taxes & Investment Tax Credit-43.59+81.3%24.04+501.0%4.00-91.3%46.12-30.65-49.70-12.71

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments766.24+25.7%724.48+34.0%609.69+23.2%709.60+27.4%609.44+8.2%540.63+61.6%495.04+32.8%556.78+27.2%
Short Term Receivables691.64-9.0%719.15-12.5%709.19-13.4%761.70+1.7%760.31+2.1%821.64+9.2%819.12+6.6%749.03-4.7%
Inventories110.10-9.4%116.02-2.0%119.84-0.4%118.59+3.0%121.59+12.3%118.40+12.8%120.36+13.5%115.09+9.1%
Other Current Assets602.47+29.3%495.23+24.9%581.43+77.9%468.93+13.9%466.11+69.9%396.44+28.2%326.75+34.4%411.84+42.4%
Total Current Assets2,170.45+10.9%2,054.88+9.5%2,020.14+14.7%2,058.82+12.3%1,957.46+15.8%1,877.11+25.0%1,761.27+18.2%1,832.75+13.3%
Net Property, Plant & Equipment2,113.62+0.7%2,128.79+3.0%2,142.16+3.8%2,144.02+5.1%2,099.31+4.5%2,067.26+3.4%2,063.73+3.4%2,039.05+1.3%
Total Investments and Advances19.1818.800.00-100.0%0.00-100.0%0.00-100.0%0.00-100.0%1.36-86.2%3.26-64.2%
Intangible Assets948.88-1.9%966.94+1.3%967.60+1.5%968.79+4.3%967.60+4.2%954.61+2.8%953.52+2.6%929.01+0.8%
Deferred Tax Assets3.20-82.6%5.82-65.9%6.65-58.0%6.89-98.2%18.41-47.0%17.07-50.8%15.84-50.9%383.85-4.9%
Other Assets97.68-12.5%104.86-5.7%116.27+0.6%49.79-62.1%111.59-16.7%111.19-18.6%115.55-8.2%131.50+1.7%
Total Assets5,353.02+3.9%5,280.08+5.0%5,252.82+7.0%5,290.21-0.7%5,154.37+7.4%5,027.25+9.1%4,911.26+6.9%5,327.63+4.4%
Short Term Debt Incl. Current Port. of LT Debt28.76+48.7%28.57+47.8%37.63+111.9%76.94+38.3%19.34+58.9%19.33+80.3%17.76+6.7%55.62-8.9%
Accounts Payable399.04+4.5%429.77+17.9%419.72+12.9%457.94+14.1%381.85+3.5%364.45-1.8%371.92-2.9%401.25-15.4%
Income Tax Payable---15.01-1.2%---15.20-15.6%
Other Current Liabilities589.56+8.8%517.98+4.2%494.13+12.2%496.66+4.9%541.96+7.0%497.09-5.6%440.46+1.2%473.36+7.5%
Total Current Liabilities1,017.36+7.9%976.32+10.8%951.48+14.6%1,046.54+10.7%943.15+6.3%880.87-3.0%830.14-0.6%945.42-4.9%
Long Term Debt2,236.38-0.9%2,237.76-0.4%2,248.09-0.5%2,241.01+0.6%2,256.25+0.7%2,247.35+0.4%2,258.50-3.0%2,226.57-4.7%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities-------371.53+0.1%
Other Liabilities317.60-1.7%324.60+28.5%322.04+24.8%317.69+21.4%323.12+13.1%252.66-15.7%258.14-18.2%261.75-18.1%
Total Liabilities3,571.34+1.4%3,538.67+4.7%3,521.61+5.2%3,605.24-5.3%3,522.53+3.2%3,380.88-1.9%3,346.78-3.8%3,805.27-5.4%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity1,396.18+12.8%1,350.55+7.6%1,336.83+13.8%1,287.90+13.8%1,238.21+23.1%1,254.59+69.6%1,175.15+68.1%1,131.38+68.6%
Total Shareholders Equity1,396.18+12.8%1,350.55+7.6%1,336.83+13.8%1,287.90+13.8%1,238.21+23.1%1,254.59+69.6%1,175.15+68.1%1,131.38+68.6%
Accumulated Minority Interest385.50-2.1%390.86-0.2%394.39+1.3%397.07+1.6%393.63+3.3%391.79-7.3%389.32-6.4%390.98-5.0%
Total Equity1,781.68+9.2%1,741.40+5.8%1,731.22+10.7%1,684.96+10.7%1,631.85+17.7%1,646.38+41.6%1,564.48+40.3%1,522.36+40.7%
Total Liabilities & Stockholders Equity5,353.02+3.9%5,280.08+5.0%5,252.82+7.0%5,290.21-0.7%5,154.37+7.4%5,027.25+9.1%4,911.26+6.9%5,327.63+4.4%
Book Value Per Share per share9.91+14.6%9.52+8.6%9.34+13.6%9.01+13.6%8.65+22.7%8.77+69.3%8.22+68.4%7.93+69.4%
Tangible Book Value Per Share per share3.17+67.7%2.70+28.6%2.58+66.5%2.23+57.0%1.89+250.0%2.101.551.42
Full-Time Employees people---25,200+1.2%---24,900
Price to Book Ratio ratio1.781.050.951.021.511.661.732.42
Return on Assets %2.781.522.642.564.125.294.734.03
Return on Equity %11.106.0110.6911.2318.2825.5623.9723.34
Return on Invested Capital %1.230.471.111.27-0.672.081.213.40
Quick Ratio ratio2.031.992.001.851.952.001.981.82
Current Ratio ratio2.132.102.121.972.082.132.121.94

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income63.39+5138.8%34.69-63.8%58.49-0.8%74.26-47.3%1.21-97.4%95.70+42.9%58.97+28.6%140.89+1207.0%
Depreciation41.06+4.9%41.34+5.2%42.99+18.8%41.04+8.4%39.16+6.5%39.31+8.3%36.20+2.4%37.85+5.2%
Other Funds (Non Cash)3.95-63.3%9.67-14.6%-1.14-112.0%10.29+10.5%10.76-12.1%11.32+486.5%9.49+191.1%9.31
Funds from Operations115.53+68.1%89.20-38.7%99.91-2.7%154.30-26.7%68.73-29.6%145.53+40.0%102.71+21.1%210.41+412.7%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital6.40-92.3%107.53-160.1369.1483.06-28.04-299.9%-127.50-90.84-443.3%
Cash from Operating Activities121.93-19.7%196.74+67.5%-60.22223.44+86.9%151.80+64.7%117.49-0.4%-24.79119.57+77.1%
Capital Expenditures-48.81-38.68-28.09-84.00-58.80-46.20-22.91-81.27
Net Assets From Acquisitions0.000.000.00-2.500.000.000.00-27.50
Sale of Fixed Assets and Businesses0.000.000.000.00-100.0%0.000.000.004.30
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.32+88.2%-0.320.000.090.17-0.05-0.21-0.97-231.1%
Other Sources8.36-0.190.190.180.000.00-100.0%0.000.00
Cash from Investing Activities-40.14-39.18-27.90-86.23-58.63-46.25-23.12-105.44
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock-10.98-13.030.000.000.00-100.0%0.000.00-0.90
Repurchase of Common Pref Stock-10.98-13.030.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.00-100.0%0.000.00-0.90
Proceedsfrom Stock Options0.000.000.000.000.00-100.0%0.000.00-0.90
Issuance or Reduction of Debt, Net-3.84-3.29-3.64-3.48-1.61-1.51-1.39-2.04-188.7%
Change in Long Term Debt-3.84-3.29-3.64-3.48-1.61-1.51-1.39-2.04-188.7%
Issuance of Long Term Debt0.000.000.000.000.000.00-100.0%0.00-100.0%0.00-100.0%
Reduction of Long Term Debt-3.84-3.29-3.64-3.48-1.61-1.51-1.39-2.04
Net Financing Active Other Cash Flow-25.21-26.45-8.14-33.56-22.75-24.15-12.45-17.55
Other Financing Activities Uses-30.95-27.16-25.18-33.56-27.39-24.15-23.40-22.79
Cash from Financing Activities-40.03-42.77-11.79-37.05-24.36-113.5%-25.66-13.83-20.48
Net Change in Cash41.76-39.3%114.78+151.8%-99.91100.1668.81-69.9%45.59-61.74-6.36
Free Cash Flow73.12-21.4%158.06+121.7%-88.31139.44+264.1%93.00+91.0%71.29-9.8%-47.7038.30+281.1%
Price to Free Cash Flow ratio5.194.665.634.9012.0817.4816.3519.12

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Services-General Medical & Surgical Hospitals, NEC5,966.076,324.34+6.0%100.0%
Total5,966.076,324.34+6.0%100.0%
Region
Name20242025vs 20242025 share
United States5,966.076,324.34+6.0%100.0%
Total5,966.076,324.34+6.0%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3015.69%3.4M22.0M431.22K
2026-10-1517.07%3.8M22.0M458.16K
2026-09-3021.07%4.6M22.0M456.99K
2026-09-1520.82%4.6M22.0M484.26K
2026-08-3117.74%3.9M22.0M534.20K
2026-08-1418.85%4.1M22.0M557.48K
2026-07-3119.34%4.3M22.3M560.89K
2026-07-1520.64%4.6M22.3M528.74K
2026-06-3020.11%4.5M22.3M490.41K
2026-06-1516.20%3.6M22.4M449.70K
2026-05-2913.47%3.0M22.5M395.06K
2026-05-1512.81%2.9M22.5M401.02K
2026-04-3013.82%3.1M22.5M396.20K
2026-04-1513.09%2.9M22.4M396.60K
2026-03-3112.28%2.8M23.2M404.18K
2026-03-1312.01%2.8M23.2M424.88K
2026-02-2711.47%2.7M23.2M452.76K
2026-02-1310.99%2.6M23.2M524.89K
2026-01-3012.46%2.9M23.2M563.62K
2026-01-1512.48%2.9M23.2M554.23K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5014.5016.900.00-0.000.000.994-0.0200.000
call5.0012.0014.405.591159.4%0.000.000.970-0.0670.002
call7.508.6011.904.84815.7%3.000.000.956-0.0650.002
call10.007.409.007.79526.6%43.000.000.937-0.0610.003
call12.504.906.502.90379.5%1630.000.909-0.0560.004
call15.002.454.001.30255.4%7.000.000.853-0.0460.006
call17.500.402.050.69191.0%1.000.000.560-0.0860.010
call20.000.000.750.95151.0%2.000.000.328-0.0910.009
put2.500.000.050.05-8.000.00-0.006-0.0180.000
put5.000.000.400.05594.3%7.000.00-0.030-0.0660.002
put7.500.000.750.05418.4%15.000.00-0.044-0.0640.002
put10.000.000.350.15295.9%7.000.00-0.063-0.0600.003
put12.500.000.350.03199.8%15.000.00-0.092-0.0540.004
put15.000.000.250.05117.0%45.000.00-0.148-0.0440.006
put17.500.000.751.0081.6%13.000.00-0.440-0.0840.010
put20.000.902.6510.93103.8%0.000.00-0.672-0.0880.009

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-128-KCurrent report2026-11-12SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-238-KCurrent report2026-10-19SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-048-KCurrent report2026-09-04SEC
2026-08-27144Filing for proposed sale of securities under Rule 144.SEC
2026-08-25144Filing for proposed sale of securities under Rule 144.SEC
2026-08-20144Filing for proposed sale of securities under Rule 144.SEC
2026-08-18144Filing for proposed sale of securities under Rule 144.SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-308-KCurrent report2026-06-26SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-028-KCurrent report2026-06-02SEC
2026-05-268-KCurrent report2026-05-20SEC
2026-05-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-058-KCurrent report2026-05-05SEC
2026-04-08ARSAnnual report to security holders. 2025-12-31SEC
2026-04-08DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-08DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-05-20SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-06186.40K200
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
CHAI TRUST CO LLC53.89%
Ventas, Inc.6.52%
BlackRock, Inc.1.52%
AMERIPRISE FINANCIAL INC1.47%
GOLDENTREE ASSET MANAGEMENT LP1.10%
AQR CAPITAL MANAGEMENT LLC1.01%
CastleKnight Management LP0.75%
VANGUARD CAPITAL MANAGEMENT LLC0.67%
AMERICAN CENTURY COMPANIES INC0.64%
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.59%

Funds

Fund% owned
Floating Rate Income Fund1.85%
Touchstone Funds Group Trust-Touchstone High Yield Fund0.86%
Columbia Small Cap Value Discovery Fund0.72%
High Income Fund0.52%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.46%
iShares Russell 2000 ETF0.45%
EA Bridgeway Omni Small-Cap Value ETF0.38%
Avantis U.S. Small Cap Value ETF0.37%
AVIP High Income Bond Portfolio0.37%
Columbia Small Cap Value and Inflection Fund0.32%

OakChart. ARDT. Cached 15 minutes. Terms